Published July 23, 2026
On March 21, 2025, a jury in the State Court of Cobb County, Georgia awarded plaintiff John Barnes $2.1 billion — $65 million in compensatory damages and $2 billion in punitive damages — after finding that Monsanto failed to warn him about the cancer risks of Roundup. Barnes, who used the weedkiller at his home and workplace for more than 20 years, was diagnosed with non-Hodgkin lymphoma. The award was reported as the largest single-plaintiff verdict in Georgia history. Bayer, Monsanto's parent company, said it would appeal.
The Barnes verdict wasn't an isolated result. Roundup cancer attorneys are reported to have secured roughly $6 billion in combined jury verdicts against Monsanto and Bayer across 2024 and 2025, part of a pattern of plaintiff wins that has continued even as Bayer has won a majority of the cases that actually went to trial.
Verdicts of this size are part of the financial backdrop against which Bayer proposed a $7.25 billion nationwide class settlement in February 2026, aimed at capping its ongoing exposure to Roundup litigation rather than continuing to litigate cases one at a time. That settlement has since moved through preliminary approval and toward a mid-2026 fairness hearing — a process Atumio has covered separately.
A headline-grabbing verdict like this one doesn't set the payout for other plaintiffs; case values depend heavily on individual exposure history, diagnosis, and the strength of available evidence, and Bayer's appeal means the final outcome of the Barnes case itself isn't settled either. If you or a family member developed non-Hodgkin lymphoma after regular Roundup exposure, see Atumio's Roundup case page for a free case review, or start your case review directly.